PCI Biotech Holding is Biotechnology in Norway that focus on Biotech Holding ASA business. Founded in 2000. They cover business area such as pci Biotech Holding ASA, therapy, cancer, its photochemical internalization, (pci) technology platform, light-trigger endosomal release, fimaCHEM, chemotherapeutic, localize treatment, fimaVACC, t-cell induction technology, therapeutic vaccination, nucleic acid therapeutic delivery, its therapeutic product candidate, Amphinex, active compound.
2000
( 24 years old in 2024 )
Biotech Holding ASA
-
Ullernchauséen 64
0379 Oslo
Norway
Private
pci Biotech Holding ASAtherapycancerits photochemical internalization(pci) technology platformlight-trigger endosomal releasefimaCHEMchemotherapeuticlocalize treatmentfimaVACCt-cell induction technologytherapeutic vaccinationnucleic acid therapeutic deliveryits therapeutic product candidateAmphinexactive compound
* We use standard office opening hours in near PCI Biotech Holding's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PCI Biotech Holding is Biotechnology business from Norway that founded in 2000 (24 years old in 2024), PCI Biotech Holding business is focusing on Biotech Holding ASA.
PCI Biotech Holding headquarter office and corporate office address is located in Ullernchauséen 64 0379 Oslo Norway.
PCI Biotech Holding was founded in Norway.
In 2024, PCI Biotech Holding is currently focus on Biotech Holding ASA sector.
Above is snippet of Google Trends for "Biotech Holding ASA" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PCI Biotech Holding, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
